Rothschild & Co Asset Management US’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$10M Sell
176,487
-6,196
-3% -$317K 0.15% 103
2022
Q3
$7.22M Sell
182,683
-1,088
-0.6% -$48.1K 0.12% 139
2022
Q2
$8.09M Sell
183,771
-484
-0.3% -$20.9K 0.12% 134
2022
Q1
$7.35M Sell
184,255
-44,768
-20% -$1.59M 0.09% 169
2021
Q4
$9.21M Buy
+229,023
New +$8.55M 0.11% 185

Other funds holding HALO

Rothschild & Co Asset Management US's HALO Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its Halozyme (HALO) stake by 3.4% in Q4 2022, selling an estimated $317K and leaving 176,487 shares worth $10M. The position accounts for 0.15% of the portfolio, ranked #103.

Rothschild & Co Asset Management US first reported a position in HALO in Q4 2021 and has held it in 5 quarters since. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.

  • Rothschild & Co Asset Management US held 176,487 shares of Halozyme worth $10M as of Q4 2022.
  • Rothschild & Co Asset Management US sold 6,196 Halozyme shares in Q4 2022, an estimated $317K.
  • Halozyme made up 0.15% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #103 holding.
  • Rothschild & Co Asset Management US first reported a position in Halozyme in Q4 2021 and has held it in 5 quarters since.
  • 423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.